マイクロアレイの世界市場レポート 2025年

マイクロアレイ市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.1％で82億7,000万米ドルに成長します。予測期間の成長は、分子診断の急成長、精密医療の出現、農業での採用拡大、マイクロバイオーム研究の拡大、ヘルスケアにおける技術統合に起因しています。予測期間の主な動向としては、マイクロアレイデータ解析ツールの強化、神経疾患のバイオマーカー探索への注力、感染症研究での活用、機能ゲノミクス研究での採用、創薬研究開発での応用拡大などが挙げられます。

マイクロアレイ市場の将来的な成長は、がんの罹患率の増加が牽引すると予測されています。がんは、制御不能な細胞増殖と体の他の部分への転移を特徴とし、確立された危険因子、特定の化学物質への曝露、高齢化、乳がん、肺がん、気管支がんなどの有病性がんなどの要因によって増加傾向にあります。マイクロアレイテクノロジーは、がんに関連する遺伝子発現の変化を同定することにより、がん研究において重要な役割を果たしています。例えば、米国がん協会は、2023年に米国で15歳未満の小児が約9,910人がんと診断され、約1,040人ががんで死亡すると予測しています。そのため、がん罹患率の増加がマイクロアレイ市場成長の主要な促進要因となっています。

拡大する製薬業界は、今後のマイクロアレイ市場の成長を牽引すると予想されます。この分野には、政府機関や民間企業による医薬品や医薬品の発見、開発、生産が含まれます。マイクロアレイ技術は、遺伝子発現、遺伝子変異、分子間相互作用の詳細な解析に製薬業界で利用されており、創薬、研究開発、個別化医療における高度な研究をサポートしています。例えば、2024年5月、英国国家統計局が発表した2022年と2023年の英国ヘルスケア会計のデータによると、2022年から2023年にかけての総医療費は名目ベースで5.6%増加し、2022年に観測された0.9%増に比べ大幅に増加しました。このように、製薬業界の成長がマイクロアレイ市場を前進させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のマイクロアレイ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のマイクロアレイ市場：成長率分析
• 世界のマイクロアレイ市場の実績：規模と成長, 2019-2024
• 世界のマイクロアレイ市場の予測：規模と成長, 2024-2029, 2034F
• 世界のマイクロアレイ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマイクロアレイ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAマイクロアレイ
• タンパク質マイクロアレイ
• その他のタイプ
• 世界のマイクロアレイ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾患診断
• がんゲノム解析
• 創薬
• ゲノム配列解析
• 発現解析
• 毒物調査
• その他の用途
• 世界のマイクロアレイ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬業界
• バイオテクノロジー産業
• 学術研究室
• その他のエンドユーザー
• 世界のマイクロアレイ市場、タイプ別サブセグメンテーション：DNAマイクロアレイ、実績と予測, 2019-2024, 2024-2029F, 2034F
• CDNAマイクロアレイ
• オリゴヌクレオチドマイクロアレイ
• SNPマイクロアレイ
• 比較ゲノムハイブリダイゼーション（CGH）マイクロアレイ
• 世界のマイクロアレイ市場、タイプ別サブセグメンテーション：タンパク質マイクロアレイ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体マイクロアレイ
• 抗原マイクロアレイ
• 受容体マイクロアレイ
• 酵素マイクロアレイ
• 世界のマイクロアレイ市場、タイプ別サブセグメンテーション：その他のタイプ、実績と予測, 2019-2024, 2024-2029F, 2034F
• セルマイクロアレイ
• ティッシュマイクロアレイ
• RNAマイクロアレイ

第7章 地域別・国別分析

• 世界のマイクロアレイ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のマイクロアレイ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マイクロアレイ市場：競合情勢
• マイクロアレイ市場：企業プロファイル
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Arrayit Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• Merck KGaA
• Microarray Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Molecular Devices LLC
• RayBiotech Life Inc.
• NextGen Sciences Inc.
• PathogenDx Inc.
• Schott Minifab AG
• Full Moon Biosystems Inc.
• CapitalBio Technology Co. Ltd.
• Roche Diagnostics Ltd.
• BioGenomics Limited
• BioMicro Systems Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• マイクロアレイ市場2029：新たな機会を提供する国
• マイクロアレイ市場2029：新たな機会を提供するセグメント
• マイクロアレイ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Microarray is a widely employed laboratory technique that involves affixing numerous known nucleic acid fragments-ranging from tens of thousands to millions-onto a solid surface, commonly referred to as a chip. This method finds frequent application in scientific and medical research, serving purposes such as detecting specific DNA sequences and assessing gene expression.

The primary categories of microarrays include DNA microarray, protein microarray, and others. A DNA microarray consists of small DNA spots affixed to a solid substrate, utilized to determine the presence of gene mutations, such as those in BRCA1 or BRCA2, within the DNA of a particular individual. This technology is employed across various domains, including disease diagnosis, cancer genomic analysis, drug discovery, genomic sequencing, expression analysis, and toxicological research. Its users span the pharmaceutical and biotechnology industries, academic and research laboratories, and other end-users.

The microarray market research report is one of a series of new reports from The Business Research Company that provides microarray market statistics, including the microarray industry's global market size, regional shares, competitors with a microarray market share, detailed microarray market segments, market trends, and opportunities, and any further data you may need to thrive in the microarray industry. This microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microarray market size has grown strongly in recent years. It will grow from$5.19 billion in 2024 to $5.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to genomic research surge, rise in personalized medicine, pharmaceutical drug discovery, advancements in cancer research, biotechnology and life sciences expansion

The microarray market size is expected to see rapid growth in the next few years. It will grow to $8.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rapid growth in molecular diagnostics, emergence of precision medicine, increased adoption in agriculture, expansion of microbiome research, technological integration in healthcare. Major trends in the forecast period include enhancements in microarray data analysis tools, focus on biomarker discovery for neurological disorders, utilization in infectious disease research, adoption in functional genomics studies, increasing applications in drug discovery and development.

The future growth of the microarray market is anticipated to be driven by the increasing incidence of cancer cases. Cancer, characterized by uncontrolled cell growth and spread to other parts of the body, is on the rise due to factors such as established risk factors, exposure to specific chemicals, an aging population, and prevalent cancers such as breast cancer, lung cancer, and bronchial cancer. Microarray technology plays a crucial role in cancer research by enabling the identification of changes in gene expression associated with the disease. For example, the American Cancer Society estimates that around 9,910 children under the age of 15 will be diagnosed with cancer in the US in 2023, with approximately 1,040 children expected to succumb to the disease. Therefore, the increasing incidence of cancer cases is a key driver for the growth of the microarray market.

The expanding pharmaceutical industry is expected to drive the growth of the microarray market in the future. This sector encompasses the discovery, development, and production of drugs and medicines by both governmental and private organizations. Microarray technology is utilized within the pharmaceutical industry for detailed analysis of gene expression, genetic variations, and molecular interactions, supporting advanced research in drug discovery, development, and personalized medicine. For instance, in May 2024, data from the UK Health Accounts for 2022 and 2023, published by the UK Office for National Statistics, indicated that total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, a substantial rise compared to the 0.9% growth observed in 2022. Thus, the growth of the pharmaceutical industry is propelling the microarray market forward.

A noteworthy trend in the microarray market is the emphasis on product innovation by major market players. These companies are actively working on creating innovative products to strengthen their market position. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based supplier of analytical instruments, life sciences solutions, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array. This chromosomal microarray is designed to enhance productivity, efficiency, and profitability in cytogenetic research labs, boasting an industry-leading two-day turnaround time. It offers comprehensive analysis of the entire human genome with enhanced coverage across 5,000 critical genomic regions, providing valuable insights into chromosomal variants for applications such as prenatal and postnatal research, as well as cancer-related studies.

Leading companies in the microarray market are focusing on the development of chromosomal microarrays to solidify their market position. Chromosomal Microarray Analysis (CMA) is considered a transformative technology in genomic medicine, significantly advancing diagnostic capabilities. For instance, in August 2023, Thermo Fisher Scientific Inc. introduced the Applied Biosystems CytoScan HD Accel array, contributing to improved productivity, efficiency, and profitability in cytogenetic research labs. This microarray facilitates comprehensive analysis of chromosomal variants for a broad range of research applications, including prenatal, postnatal, and oncology studies.

In May 2024, Bruker, a U.S.-based manufacturer of analytical instrumentation and scientific solutions, acquired NanoString's business for an undisclosed sum. This acquisition is intended to bolster Bruker's position in the life sciences sector and enhance its portfolio of analytical tools and solutions. NanoString is a U.S.-based biotechnology company known for producing DNA and protein microarrays as well as biosensors.

Major companies operating in the microarray market include Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., NextGen Sciences Inc., PathogenDx Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics, Ltd., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, Affymetrix Inc., SCIENION AG, INanoBio Inc.

North America was the largest region in the microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The microarray market consists of revenues earned by entities by providing services such as genotyping and methylation array services, analytical protein microarray, functional protein array, reverse-phase protein array, and peptide microarray. The value of associated goods sold by the service provider or incorporated into the service providing is included in the market value. The microarray market also includes sales of microarray slides or chips and priming, microarray fluorescence and colorimetric scanners, printers, hybridization stations or DNA and RNA assays, whole genome sequencing, cDNA Microarray, BAC microarray, oligo microarray, which are used in providing microarray services. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: DNA Microarray; Protein Microarray; Other Types
• 2) By Application: Disease Diagnosis; Cancer Genomic Analysis; Drug Discovery; Genomic Sequencing; Expression Analysis; Toxicological Research; Other Applications
• 3) By End-User: Pharmaceutical Industry; Biotechnology Industry; Academic and Research Laboratories; Other End-Users
• Subsegments:
• 1) By DNA Microarray: CDNA Microarray; Oligonucleotide Microarray; SNP Microarray; Comparative Genomic Hybridization (CGH) Microarray
• 2) By Protein Microarray: Antibody Microarray; Antigen Microarray; Receptor Microarray; Enzyme Microarray
• 3) By Other Types: Cell Microarray; Tissue Microarray; RNA Microarray
• Companies Mentioned: Agilent Technologies Inc.; Arrayit Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; GE Healthcare Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microarray Market Characteristics

3. Microarray Market Trends And Strategies

4. Microarray Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Microarray Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microarray Market Growth Rate Analysis
• 5.4. Global Microarray Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microarray Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microarray Total Addressable Market (TAM)

6. Microarray Market Segmentation

• 6.1. Global Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Microarray
• Protein Microarray
• Other Types
• 6.2. Global Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Diagnosis
• Cancer Genomic Analysis
• Drug Discovery
• Genomic Sequencing
• Expression Analysis
• Toxicological Research
• Other Applications
• 6.3. Global Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Industry
• Biotechnology Industry
• Academic and Research Laboratories
• Other End-Users
• 6.4. Global Microarray Market, Sub-Segmentation Of DNA Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CDNA Microarray
• Oligonucleotide Microarray
• SNP Microarray
• Comparative Genomic Hybridization (CGH) Microarray
• 6.5. Global Microarray Market, Sub-Segmentation Of Protein Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Microarray
• Antigen Microarray
• Receptor Microarray
• Enzyme Microarray
• 6.6. Global Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Microarray
• Tissue Microarray
• RNA Microarray

7. Microarray Market Regional And Country Analysis

• 7.1. Global Microarray Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microarray Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microarray Market

• 8.1. Asia-Pacific Microarray Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microarray Market

• 9.1. China Microarray Market Overview
• 9.2. China Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microarray Market

• 10.1. India Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microarray Market

• 11.1. Japan Microarray Market Overview
• 11.2. Japan Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microarray Market

• 12.1. Australia Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microarray Market

• 13.1. Indonesia Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microarray Market

• 14.1. South Korea Microarray Market Overview
• 14.2. South Korea Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microarray Market

• 15.1. Western Europe Microarray Market Overview
• 15.2. Western Europe Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microarray Market

• 16.1. UK Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microarray Market

• 17.1. Germany Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microarray Market

• 18.1. France Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microarray Market

• 19.1. Italy Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microarray Market

• 20.1. Spain Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microarray Market

• 21.1. Eastern Europe Microarray Market Overview
• 21.2. Eastern Europe Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microarray Market

• 22.1. Russia Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microarray Market

• 23.1. North America Microarray Market Overview
• 23.2. North America Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microarray Market

• 24.1. USA Microarray Market Overview
• 24.2. USA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microarray Market

• 25.1. Canada Microarray Market Overview
• 25.2. Canada Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microarray Market

• 26.1. South America Microarray Market Overview
• 26.2. South America Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microarray Market

• 27.1. Brazil Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microarray Market

• 28.1. Middle East Microarray Market Overview
• 28.2. Middle East Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microarray Market

• 29.1. Africa Microarray Market Overview
• 29.2. Africa Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microarray Market Competitive Landscape And Company Profiles

• 30.1. Microarray Market Competitive Landscape
• 30.2. Microarray Market Company Profiles
  • 30.2.1. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Arrayit Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Microarray Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. Merck KGaA
• 31.3. Microarray Inc.
• 31.4. PerkinElmer Inc.
• 31.5. Thermo Fisher Scientific Inc.
• 31.6. Molecular Devices LLC
• 31.7. RayBiotech Life Inc.
• 31.8. NextGen Sciences Inc.
• 31.9. PathogenDx Inc.
• 31.10. Schott Minifab AG
• 31.11. Full Moon Biosystems Inc.
• 31.12. CapitalBio Technology Co. Ltd.
• 31.13. Roche Diagnostics Ltd.
• 31.14. BioGenomics Limited
• 31.15. BioMicro Systems Inc.

32. Global Microarray Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microarray Market

34. Recent Developments In The Microarray Market

35. Microarray Market High Potential Countries, Segments and Strategies

• 35.1 Microarray Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microarray Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microarray Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer